Abstract
Cancer is still considered a “hopeless case”, besides all of the advancements in oncology research. On the other hand, the natural products, as effective lead molecules, have gained significant interest for research due to the absence of toxic and harmful side effects usually associated with conventional treatment methods. Medicinal properties of herbal plants are strongly evidenced in traditional medicine from ancient times. In the context above, withaferin A (WA) was identified as the active principle of the plant Withania somnifera, its molecule being reported to have excellent anticancer and tumour inhibition activities in various cell lines. Furthermore, the in silico approaches in the medicinal chemistry of WA revealed the biological targets and gave momentum for the research that leads to many amazing pharmacological activities of WA which are not yet explored. This includes a broad spectrum of anticancer actions manifested in different organs (breast, pancreas, colon), melanoma and B cell lymphoma, etc. This review is an extensive survey of the most recent anticancer studies reported for WA, along with its mechanism of action and details about its in vitro and/or in vivo behaviour.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ali HR, Dawson SJ, Blows FM, Provenzano E, Leung S, Nielsen T, Pharoah PD, Caldas C (2012) A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer. J Pathol 226:97–107. https://doi.org/10.1002/path.2976
Aqil F, Munagala R, Gupta RC (2018) Withaferin a inhibits epithelial to mesenchymal transition in non-small cell lung Cancer cells. Sci Rep 8:15737. https://doi.org/10.1038/s41598-018-34018-1
Banu MR, Ibrahim M, Prabhu K, Rajasankar S (2019a) Ameliorative effect of Withaferin A on ageing-mediated impairment in the dopamine system and its associated behavior of Wistar albino rat. Pharmacology 103(3-4):114–119. https://doi.org/10.1159/000495510
Banu MR, Ibrahim M, Prabu K, Rajasankar S. (2019b) Neuroprotective efficacy of withaferin a on aging mediated oxidative stress in striatum and Substantia nigra of wistar albino rat. Drug Invention Today 12(3), JPRS-P col-00003270
Bargagna-Mohan P, Hamza A, Kim YE, Khuan (Abby) Ho Y, Mor-Vaknin N, Wendschlag N, Liu J, Evans RM, Markovitz DM, Zhan CG, Kim KB, Mohan R (2007) The tumor inhibitor and antiangiogenic agent withaferin a targets the intermediate filament protein vimentin. Chem Biol 14:623–634. https://doi.org/10.1016/j.chembiol.2007.04.010
Bratu OG, Cherciu AI, Bumbu A, Lupu S, Marcu DR, Ionita Radu F, Manea M, Furau C, Diaconu CC, Mischianu DLD (2019) Retroperitoneal tumors – treatment and prognosis of tumor recurrence. Rev Chim 70(1):191–194
Bungau SG, Popa V-C (2015) Between religion and science: some aspects: concerning illness and healing in antiquity. Transylvanian Review 24(3):3–18
Chandrasekaran B, Pal D, Kolluru V, Tyagi A, Baby B, Dahiya NR, Youssef K, Alatassi H, Ankem MK, Sharma AK, Damodaran C (2018) The chemopreventive effect of withaferin a on spontaneous and inflammation-associated colon carcinogenesis models. Carcinogenesis 39(12):1537–1547. https://doi.org/10.1093/carcin/bgy109
Chang E, Patel C, Pohling C, Beygui N, Ha DH, Gambhir SS (2018) Withaferin A and tumor treating fields synergistically inhibit glioma proliferation. 78 (13s) https://doi.org/10.1158/1538-7445.AM2018-5828
Chirumamilla C, Pérez-Novo C, Van Ostade X, Vanden Berghe W (2017) Molecular insights into cancer therapeutic effects of the dietary medicinal phytochemical withaferin. Proc Nutr Soc 76(2):96–105. https://doi.org/10.1017/S0029665116002937
Davis L, Girija K (2000) Immunomodulatory activity of Withania somnifera. J Ethnopharmacol 71(1–2):193–200. https://doi.org/10.1016/s0378-8741(99)00206-8
Devi PU, Sharada AC, Solomon FE, Kamath MS (1992) In vivo growth inhibitory effect of Withaniasomnifera (Ashwagandha) on a transplantable mouse tumor, sarcoma 180. Indian J Exp Biol 30:169–172
Dubey S, Yoon H, Cohen MS, Nagarkatti P, Nagarkatti M, Karan D (2018) Withaferin A associated differential regulation of inflammatory cytokines. Front Immunol 9:195. https://doi.org/10.3389/fimmu.2018.00195
Dutta R, Khalil R, Green R, Mohapatra SS, Mohapatra S (2019) Withania Somnifera (Ashwagandha) and withaferin A: potential in integrative oncology. Int J Mol Sci 20(21):5310. https://doi.org/10.3390/ijms20215310
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917
Fong MY, Jin S, Rane M, Singh RK, Gupta R, Kakar SS (2012) Withaferin A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancer. PLoS One 7(7):e42265. https://doi.org/10.1371/journal.pone.0042265
Gheorghe G, Pantea Stoian A, Gaman MA, Socea B, Neagu TP, Stanescu AMA, Bratu OG, Mischianu DLD, Suceveanu AI, Diaconu CC (2019) The benefits and risks of antioxidant treatment in liver diseases. Rev Chim 70(2):651–655
Glevitzky I, Dumitrel GA, Glevitzky M, Pasca B, Otrisal P, Bungau S, Cioca G, Pantis C, Popa M (2019) Statistical analysis of the relationship between antioxidant activity and the structure of flavonoid compounds. Rev Chim 70(9):3103–3107
Guo R, Gan L, Lau WB, Yan Z, Xie D, Gao E, Christopher TA, Lopez BL, Ma X, Wang Y (2019) Withaferin A prevents myocardial ischemia/reperfusion injury by upregulating AMP-activated protein kinase-dependent B-cell lymphoma2 signalling. Circ J 83(8):1726–1736. https://doi.org/10.1253/circj.CJ-18-1391
Gusella M, Frigo AC, Bolzonella C, Marinelli R, Barile C, Bononi A, Crepaldi G, Menon D, Stievano L, Toso S, Pasini F, Ferrazzi E, Padrini R (2009) Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer. Br J Cancer 100(10):1549–1557. https://doi.org/10.1038/sj.bjc.6605052
Hahm ER, Moura MB, Kelley EE, Van Houten B, Shiva S, Singh SV (2011) Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species. PLoS One 6(8):e23354. https://doi.org/10.1371/journal.pone.0023354
Harris MH, Thompson CB (2000) The role of the Bcl-2 family in the regulation of outer mitochondrial membrane permeability. Cell Death Differ 7:1182–1191. https://doi.org/10.1038/sj.cdd.4400781
Hsu JH, Chang PM, Cheng TS et al (2019) Identification of withaferin a as a potential candidate for anti-cancer therapy in non-small cell lung cancer. Cancers (Basel) 11(7):1003. https://doi.org/10.3390/cancers11071003
Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics, 2010 [published correction appears in CA Cancer J Clin 2011 Mar-Apr;61(2):133-4]. CA Cancer J Clin 60(5): 277–300. 10.3322/caac.20073
Kakar SS, Ratajczak MZ, Powell KS, Moghadamfalahi M, Miller DM, Batra SK, Singh SK (2014) Withaferin a alone and in combination with Cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative Cancer stem cells. PLoS One 9(9):e107596. https://doi.org/10.1371/journal.pone.0107596
Khalilpourfarshbafi M, Murugan DD, Sattar MZ, Sucedaram Y, Abdullah NA (2019) Withaferin a inhibits adipogenesis in 3T3-F442A cell line, improves insulin sensitivity and promotes weight loss in high fat diet-induced obese mice. PLoS One 14(6):e0218792. https://doi.org/10.1371/journal.pone.0218792
Kumar M, Liu ZR, Thapa L, Wang DY, Tian R, Qin RY (2004) Mechanisms of inhibition of growth of human pan-creatic carcinoma implanted in nude mice by somatostatin receptor subtype 2. Pancreas 29(2):141–151. https://doi.org/10.1097/00006676-200408000-00009
Lee IC, Choi BY (2016) Withaferin-A--a natural anticancer agent with pleitropic mechanisms of action. Int J Mol Sci 17(3):290. https://doi.org/10.3390/ijms17030290
Lee J, Hahm ER, Singh SV (2010) Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells. Carcinogenesis 31(11):1991–1998. https://doi.org/10.1093/carcin/bgq175
Lipponen P, Pietilainen T, Kosma VM, Aaltomaa S, Eskelinen M, Syrjaunen K (1995) Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J Pathol 177:49–55. https://doi.org/10.1002/path.1711770109
Lipponen P (1999) Apoptosis in breast cancer: relationship with other pathological parameters. Endocr Relat Cancer 6:13–16. https://doi.org/10.1677/erc.0.0060013
Liu W, Wang G, Palovcak A, Li Y, Hao S, Liu ZJ, Landgraf R, Yuan F, Zhang Y (2019) Impeding the single-strand annealing pathway of DNA double-strand break repair by withaferin A-mediated FANCA degradation. DNA repair 1(77):10–17. https://doi.org/10.1016/j.dnarep.2019.02.010
Malik F, Kumar A, Bhushan S, Khan S, Bhatia A, Suri KA, Qazi GN (2007) Singh J. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis. 12:2115–2133. https://doi.org/10.1007/s10495-007-0129-x
Manoharan S, Panjamurthy K, Pugalendi P, Balakrishnan S, Rajalingam K, Vellaichamy J, Alias L (2009) Protective role of withaferin-a on red blood cell integrity during 7,12dimethylbenz[a]anthracene induced oral carcinogenesis. Afr J Trad CAM 6(1):94–102. https://doi.org/10.4314/ajtcam.v6i1.57079
Massague J (2004) G1 cell-cycle control and cancer. Nature 432:298–306. https://doi.org/10.1038/nature03094
Mathur R, Gupta SK, Singh N, Mathur S, Kochupillai V, Velpandian T (2006) Evaluation of the effect of Withania somnifera root extracts on cell cycle and angiogenesis. J Ethnopharmacol 105:336–341. https://doi.org/10.1016/j.jep.2005.11.020
Michl P, Gress TM (2013) Current concepts and novel tar-gets in advanced pancreatic cancer. Gut 62(2):317–326. https://doi.org/10.1136/gutjnl-2012-303588
Mogoanta SS, Costache A, Mutiu G, Bungau SG, Ghilusi M, Grosu F, Vasile M, Vilcea ID, Gherghinescu MC, Mogoanta L, Ion DA (2015) A nonfunctional neuroendocrine tumor of the pancreas – a case report. Rom J Morphol Embriol 56(2 Suppl):511–159
Mohan R, Hammers H, Bargagna-Mohan P, Zhan X, Herbstritt C, Ruiz A, Zhang L, Hanson A, Conner B, Rougas J, Pribluda V (2004) Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis 7(2):115–122. https://doi.org/10.1007/s10456-004-1026-3
Munagala R, Kausar H, Munjal C, Gupta RC (2011) Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Carcinogenesis 32(11):1697–1705. https://doi.org/10.1093/carcin/bgr192
Muniraj N, Siddharth S, Nagalingam A, Walker A, Woo J, Győrffy B, Gabrielson E, Saxena NK, Sharma D (2019) Withaferin A inhibits lysosomal activity to block autophagic flux and induces apoptosis via energetic impairment in breast cancer cells. Carcinogenesis. https://doi.org/10.1093/carcin/bgz015
O'Regan RM, Jordan VC (2002) The evolution of tamoxifen therapy in breast cancer: selective oestrogen-receptor modulators and down regulators. Lancet Oncol 3:207–214. https://doi.org/10.1016/S1470-2045(02)00711-8
Ouyang L, Luo Y, Tian M, Zhang SY, Lu R, Wang JH, Kasimu R, Li X (2014) Plant natural products: from traditional compounds to new emerging drugs in cancer therapy. Cell Prolif 47:506–515. https://doi.org/10.1111/cpr.12143
Pallag A, Rosca E, Tit DM, Mutiu G, Bungau SG, Pop OL (2015) Monitoring the effects of treatment in colon cancer cells using immunohistochemical and histoenzymatic techniques. Rom J Morph Embriol 56(3):1103–1109
Paraschiv B, Toma CL, Diaconu C (2013) Bronchiolo-alveolar carcinoma in a young patient: a case report. Arch Bronconeumol 49(7):315–316
Peddakkulappagari CS, Saifi MA, Khurana A, Anchi P, Singh M, Godugu C (2019) Withaferin A ameliorates renal injury due to its potent effect on inflammatory signaling. BioFactors 45(5):750–762. https://doi.org/10.1002/biof.1534
Pires N, Gota V, Gulia A, Hingorani L, Agarwal M, Puri A (2019) Safety and pharmacokinetics of withaferin-a in advanced stage high grade osteosarcoma: a phase I trial. Ayurveda Integr Med 11:68–72. https://doi.org/10.1016/j.jaim.2018.12.008
Prakash J, Gupta SK, Kochupillai V, Singh N, Gupta YK, Joshi S (2001) Chemopreventive activity of Withaniasomnifera in experimentally induced fibrosarcomatumours in Swiss albino mice. Phytother Res 15:240–244. https://doi.org/10.1002/ptr.779
Scartezzini P, Speroni E (2000) Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol 71:23–43. https://doi.org/10.1016/S0378-8741(00)00213-0
Shao Q, Feng Y, Wang W, Wang M, Li B, el Tahchi M, Yin Y (2020) Drug carrier for sustained release of withaferin a for pancreatic cancer treatment. J Mater Sci 55:1702–1714. https://doi.org/10.1007/s10853-019-04139-7
Siegel R, Naishadham D, Jemal A (2012) Cancer statistics. CA Cancer J Clin 62(1):10–29
Simpson ER, Dowsett M (2002) Aromatase and its inhibitors: significance for breast cancer therapy. Recent Prog Horm Res 57:317–338. https://doi.org/10.1210/rp.57.1.317
Singh MP, Vashisht S, Chawla V, Mishra P (2016) Comparative antistress effect of Vitis vinifera and Withania somnifera using unpredictable chronic mild stress model in rats. International Journal of Medical Research & Health Sciences 7:19–27
Srinivasan S, Ranga RS, Burikhanov R, Han SS, Chendil D (2007) Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Cancer Res 67(1):246–253. https://doi.org/10.1158/0008-5472.CAN-06-2430
Stan SD, Hahm ER, Warin R, Singh SV (2008a) Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Cancer Res 68:7661–7669. https://doi.org/10.1158/0008-5472.CAN-08-1510
Stan SD, Zeng Y, Singh SV (2008b) Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells. Nutr Cancer 60(S1):51–60. https://doi.org/10.1080/01635580802381477
Su HT, Weng CC, Hsiao PJ, Chen LH, Kuo TL, Chen YW, Kuo KK, Cheng KH (2013) Stem cell marker nestin is critical for TGF-beta1-mediated tumor progression in pancreatic cancer. Mol. Cancer Res 11:768–779. https://doi.org/10.1158/1541-7786.MCR-12-0511
Sumathi S, Padma S, Gathampari S, Vidhya S (2007) Free radical scavenging activity of different parts of Withania Somnifera. Anc Sci Life 26(3):30–34
Tataru A-L, Furau G, Afilon J, Ionescu C, Dimitriu M, Bratu OG, Tit DM, Bungau S, Furau C (2019) The situation of cervical cancers in the context of female genital cancers clustering and burden of disease in Arad County, Romania. J Clin Med 8(1). https://doi.org/10.3390/jcm8010096
Thaiparambil JT, Bender L, Ganesh T, Kline E, Patel P, Liu Y, Tighiouart M, Vertino PM, Harvey RD, Garcia A, Marcus AI (2011) Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. Int J Cancer 129(11):2744–2755. https://doi.org/10.1002/ijc.25938
Tit DM, Bungau S, Iovan C, Nistor Cseppento DC, Endres L, Sava C, Sabau AM, Furau G, Furau C (2018) Effects of the hormone replacement therapy and of soy isoflavones on bone resorption in postmenopause. J Clin Med 7:297. https://doi.org/10.3390/jcm7100297
Tomita M, Matsuzaki Y, Edagawa M, Shimizu T, Hara M, Onitsuka T (2003) Prognostic significance of bcl-2 expression in resected pN2 non-small cell lung cancer. Eur J SurgOncol 29:654–657. https://doi.org/10.1016/s0748-7983(03)00138-0
Vanden Berghe W, Sabbe L, Kaileh M, Haegeman G, Heyninck K (2012) Molecular insight in the multifunctional activities of Withaferin A. Biochem Pharmacol 84:1282–1291. https://doi.org/10.1016/j.bcp.2012.08.027
Vyas AR, Singh SV (2014) Molecular targets and mechanisms of cancer prevention and treatment by withaferin-a, a naturally occurring steroidal lactone. AAPS J 16:1–10. https://doi.org/10.1208/s12248-013-9531-1
Xia S, Miao Y, Liu S (2018) Withaferin A induces apoptosis by ROS-dependent mitochondrial dysfunction in human colorectal cancer cells. Biochemical and biophysical research communications. 18; 503(4): 2363–9
Xu L, Zhu F, Jiang J et al (2015) Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells. Cancer Lett 357:219–230. https://doi.org/10.1016/j.bbrc.2018.06.162
Yassin AM, El-Deeb NM, Elsaid FG, Shati AA, Cioca G, Tit DM, Bungau S, Popa A, Hafez EE (2019) Lectin from Pisum fulvum seeds as in vitro anticancer and apoptotic gene regulator. Rev Chim 70(4):1490–1495
Yu Y, Hamza A, Zhang T, Gu M, Zou P, Newman B, Li Y, Gunatilaka AL, Zhan CG, Sun D (2010) Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochem Pharmacol 79(4):542–551. https://doi.org/10.1016/j.bcp.2009.09.017
Zaha DC, Jurca CM, Bungau S, Cioca G, Popa A, Sava C, Endres L, Vesa CM (2019) Luminal versus non-luminal breast cancer CDH1 immunohistochemical expression. Rev Chim 70(2):465–469. https://doi.org/10.37358/RC.19.2.6936
Zaha DC, Lazar E (2012) Molecular characterization of apoptosis by the evaluation of Bcl-2 in breast cancer. Romanian J Morphol Embryol 53(1):155–160
Zhao HM, Gao ZW, Xie SX, Han X, Sun QS (2019) Withaferin A attenuates ovalbumin induced airway inflammation. Front Biosci (Landmark Ed) 24:576–596
Author information
Authors and Affiliations
Contributions
All authors contributed equally to this paper.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Responsible editor: Philippe Garrigues
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sivasankarapillai, V.S., Madhu Kumar Nair, R., Rahdar, A. et al. Overview of the anticancer activity of withaferin A, an active constituent of the Indian ginseng Withania somnifera. Environ Sci Pollut Res 27, 26025–26035 (2020). https://doi.org/10.1007/s11356-020-09028-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11356-020-09028-0